CTI BIOPHARMA CORP Severance Agreements
13 Contracts & Agreements
- Amendment No. 2 to Severance Agreement by and between James Fong and CTI BioPharma Corp (Filed With SEC on May 15, 2023)
- Amendment to Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of March 1, 2022 (Filed With SEC on March 4, 2022)
- Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of January 6, 2015 (Filed With SEC on March 4, 2022)
- Severance Agreement by and between CTI BioPharma Corp. and David Kirske, dated September 25, 2017 (Filed With SEC on September 26, 2017)
- SEVERANCE AGREEMENT (Filed With SEC on February 17, 2016)
- SEVERANCE AGREEMENT (Filed With SEC on March 12, 2015)
- SEVERANCE AGREEMENT (Filed With SEC on March 22, 2013)
- SEVERANCE AGREEMENT (Filed With SEC on February 28, 2013)
- FORM OF STRATEGIC MANAGEMENT TEAM SEVERANCE AGREEMENT (Filed With SEC on March 16, 2009)
- SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on May 12, 2008)
- SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on June 29, 2005)
- FORM OF STRATEGIC MANAGEMENT TEAM SEVERANCE AGREEMENT (Filed With SEC on April 18, 2005)
- STRATEGIC MANAGEMENT TEAM SEVERANCE AGREEMENT (Filed With SEC on October 4, 2004)
